India is angry with the United Kingdom for not approving the Kovishield

The UK’s decision not to approve the Covishield vaccine, produced at the Seram Institute in Pune, India, is discriminatory. This was stated by Indian Foreign Secretary Harsh Vardhan Sringla at a press conference in the capital on Tuesday, the day before Prime Minister Narendra Modi’s visit to the United States. He said if the United Kingdom did not approve Kovishield, India would have the right to take similar action.

The United Kingdom has not yet allowed Covishield vaccinators to travel to that country without hindrance. Indian Foreign Minister S Jayashankar has already spoken to British Foreign Secretary Liz Truss on the sidelines of the 7th session of the UN General Assembly.

Sringla said the decision was discriminatory, with the Foreign Minister urging the UK. He also said that if Kovishield was not approved, India would have the right to take similar decisions. Sringla said the UK had assured that the matter would be resolved.

In fact, Prime Minister Modi’s visit to the United States is a big topic of discussion for Kovid and his vaccines. In addition to the UN summit, the issue will be discussed at the summit of the quadripartite alliance quad. Prior to the US visit, India had announced a resumption of exports of surplus vaccines. The Union Health Minister made that announcement on Monday. Referring to him, Sringla said that now vaccine production in India has doubled. Immunization targets will also be met. In this situation, India has decided to give surplus vaccines to its neighbors. Will also be sent to other countries.

Sringla also gave an explanation as to why India could not accept the UK’s decision on Kovishield. He said Covishield was produced at the Seram Institute, an Indian company with a license from the British company Oxford AstraZeneca. India also officially sent a dose of 5 million Covishield tickers to the British government before exports stopped. That vaccine has definitely been given to the citizens of that country. The argument for not approving a licensed Covishield is therefore absurd.

According to the new rules for tourists in the United Kingdom, anyone who goes to that country with two vaccines of Kovishield will have to stay in the mandatory quarantine for 10 days. Jayashankar firmly told Liz Truss about that objection. He tweeted after the meeting, “I have told the foreign minister that the issue of quarantine needs to be resolved quickly in the mutual interest.”

Prime Minister Modi is leaving for the United States on Wednesday. He will be accompanied by India’s National Security Adviser Ajit Doval, Foreign Secretary Sringla and other top officials. He will attend the Quad Summit in Washington at the invitation of US President Joe Biden. This will be the first face-to-face interview of the four heads of state. Besides, Modi will also take part in the general meeting of the UN Security Council.

Modi only went to Bangladesh in a cowardly situation. This is the first time to cross the sea.
While in the United States, Modi will hold separate bilateral meetings with Biden. This will be Modi’s first face-to-face meeting with President Biden. Modi will also hold a meeting with Vice President Kamala Harris. The visit will focus on a wide range of issues, including counter-terrorism, Afghanistan and terrorism. It was not immediately clear whether Modi would hold a meeting with Bangladesh Prime Minister Sheikh Hasina on the sidelines of the UN summit.

However, many experts acknowledge that there was a shortcoming somewhere in India in ensuring the international recognition of Kovishield.

As Bhaswati Mukherjee, India’s former ambassador to the European Union and the Netherlands, told the BBC:

In other words, what is right for whites is not right for men and women with brown skin!